[Congressional Record Volume 163, Number 169 (Thursday, October 19, 2017)]
[Senate]
[Page S6695]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 1554. Mr. REED submitted an amendment intended to be proposed to 
amendment SA 1116 proposed by Mr. Enzi to the concurrent resolution H. 
Con. Res. 71, establishing the congressional budget for the United 
States Government for fiscal year 2018 and setting forth the 
appropriate budgetary levels for fiscal years 2019 through 2027; which 
was ordered to lie on the table; as follows:

       At the end of title III, add the following:

     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO 
                   PRESCRIPTION DRUG COSTS UNDER THE MEDICARE 
                   PROGRAM.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution, 
     and make adjustments to the pay-as-you-go ledger, for one or 
     more bills, joint resolutions, amendments, amendments between 
     the Houses, motions, or conference reports relating to 
     prescription drug costs under the Medicare program, which may 
     include making prescription drugs more affordable for seniors 
     and for taxpayers by requiring the Secretary of Health and 
     Human Services to negotiate prescription drug costs under the 
     Medicare program, particularly with inverted corporations 
     that benefit from Medicare program reimbursements, by the 
     amounts provided in such legislation for those purposes, 
     provided that such legislation would not increase the deficit 
     over either the period of the total of fiscal years 2018 
     through 2022 or the period of the total of fiscal years 2018 
     through 2027.
                                 ______